MYH2
protein-codingmyosin heavy chain 2, the group of Myosin heavy chains, class II
Gene summary
Myosins are actin-based motor proteins that function in the generation of mechanical force in eukaryotic cells. Muscle myosins are heterohexamers composed of 2 myosin heavy chains and 2 pairs of nonidentical myosin light chains. This gene encodes a member of the class II or conventional myosin heavy chains, and functions in skeletal muscle contraction. This gene is found in a cluster of myosin heavy chain genes on chromosome 17. A mutation in this gene results in inclusion body myopathy-3. Multiple alternatively spliced variants, encoding the same protein, have been identified. [provided by RefSeq, Sep 2009]
- IBM3
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~28.6 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0011577
Submitter: Laboratory for Molecular Medicine
This gene-disease relationship has undergone rapid assessment. Classifications are based on preliminary review of gene-disease validity during analysis of genomic sequencing results.
Inheritance Pattern: AR
Disease ID:MONDO:0018206
Submitter: Orphanet
Inheritance Pattern: SD
Disease ID:MONDO:0011577
Submitter: Ambry Genetics
Inheritance Pattern: AR
Disease ID:MONDO:0011577
Submitter: ClinGen
*MYH2* was first reported in relation to autosomal recessive proximal myopathy and ophthalmoplegia in 2000 (Tajsharghi et al., PMID: 20418530). Evidence supporting this gene-disease relationship includes case-level data from 8 probands in 3 publications (PMIDs: 20418530, 23388406, 24193343), with ten unique variants (including missense, in-frame deletions, frameshifts, and splice sites), having a loss of function mechanism. This gene-disease association is also supported by experimental evidence, including expression evidence (PMID: 7545970) in type IIa muscle fibers and a C. elegans model (PMID: 16130113). In summary, *MYH2* is definitively associated with autosomal recessive proximal myopathy and ophthalmoplegia. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time. Of note, *MYH2* has also been reported in relation to autosomal dominant proximal myopathy and ophthalmoplegia. Due to the proposed difference in mechanism, dominant negative, those cases were considered in a separate curation.
Inheritance Pattern: AR
Disease ID:MONDO:0011577
Submitter: PanelApp Australia
Inheritance Pattern: AD
Disease ID:MONDO:0011577
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0011577
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AD
Disease ID:MONDO:0011577
Submitter: PanelApp Australia
Inheritance Pattern: AD
Disease ID:MONDO:0019195
Submitter: Orphanet
Inheritance Pattern: AD
Disease ID:MONDO:0019195
Submitter: Illumina
Inheritance Pattern: AD
Disease ID:MONDO:0011577
Submitter: ClinGen
*MYH2* was first reported in relation to autosomal dominant proximal myopathy and ophthalmoplegia in 2000 (Martinsson et al., PMID: 11114175). Evidence supporting this gene-disease relationship includes case-level data from 7 probands in 6 publications (PMIDs: 11114175, 23489661, 25529940, 36380287, 36774715,41252304), with five unique variants (4 missense and 1 splice site) predominantly found in the filament assembly region except for Glu706Lys in the SH1 helix domain. A dominant negative mechanism has been suggested however has not been established. This gene-disease association is also supported by experimental evidence, including expression evidence (PMID: 7545970) in type IIa muscle fibers, functional alteration in patient cells (PMID: 17005402), and a C. elegans model (PMID: 16130113). In summary, there is moderate evidence to support this gene-disease relationship. Although more evidence is needed to support a causal role, no convincing evidence has emerged that contradicts the gene-disease relationship. This gene-disease pair was originally evaluated by the Congenital Myopathies and Myasthenic Syndromes GCEP on June 10, 2024. It was re-evaluated on June 10, 2026. As a result of this reevaluation, the classification remained Moderate with the addition of 2 new cases (PMID: 41252304). Of note, *MYH2* has also been reported in relation to autosomal recessive proximal myopathy and ophthalmoplegia. Due to the proposed difference in mechanism, loss of function, those cases were considered in a separate curation.
Clinical Genomic Database (CGD)
Manifestation: Musculoskeletal
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to MYH2 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_017534.6. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 21 | 333 | 5 | 359 | ||
| missense | 3 | 7 | 873 | 26 | 2 | 911 |
| nonsense | 24 | 13 | 2 | 39 | ||
| start loss | 3 | 3 | ||||
| frameshift | 37 | 15 | 4 | 56 | ||
| splice donor/acceptor (+/-2bp) | 4 | 30 | 34 | |||
| Total | 68 | 65 | 903 | 359 | 7 | 1402 |
Highest pathogenic variant AF is 0.000065672575
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_060004.3 | 38 | MANE Select | |
| Ensembl | ENSP00000245503.5 | 38 | MANE Select | |
| RefSeq | NP_001093582.1 | 38 | Standard | |
| Ensembl | ENSP00000380367.2 | 38 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Tight junction - Homo sapiens (human)
- amb2 Integrin signaling
- Alpha4 beta1 integrin signaling events
Biological Process
- muscle contraction
- muscle filament sliding
- Fc-gamma receptor signaling pathway involved in phagocytosis
Molecular Function
- microfilament motor activity
- protein binding
- calmodulin binding
- ATP binding
- actin filament binding
Cellular Component
- cytosol
- muscle myosin complex
- myofibril
- sarcomere
- myosin filament
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000245503
- Coding exons
- 38
- Length
- 28810
- Individuals with no LoFs
- 125566
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 182
- Defined
- 125748
- p
- 0.000724
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 1.97 | 826 | 1.00e+3 | 0.825 | 0.0000599 | 12909 |
| Missense (PolyPhen) | 254 | 325.4 | 0.78059 | 4458 | ||
| Synonymous | -0.693 | 404 | 387 | 1.04 | 0.0000228 | 3539 |
| Loss of Function | 4.15 | 53 | 97.1 | 0.546 | 0.00000527 | 1244 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00025 | 0.00025 | rare |
| Latino/Admixed American | 0.00098 | 0.00093 | rare |
| Ashkenazi Jewish | 0.000099 | 0.000099 | rare |
| East Asian | 0.00071 | 0.00071 | rare |
| Finnish | 0.0017 | 0.0017 | notable |
| European (Non-Finnish) | 0.00059 | 0.00057 | rare |
| South Asian | 0.00088 | 0.00088 | rare |
| Other | 0.00049 | 0.00049 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Muscle contraction. Required for cytoskeleton organization (By similarity). {ECO:0000250}.;
- Disease
- DISEASE: Myopathy, proximal, and ophthalmoplegia (MYPOP) [MIM:605637]: A muscular disorder characterized by mild-to- moderate muscle weakness, ophthalmoplegia, and contractures at birth in some patients. Muscle biopsies from patients show predominance of type 1 fibers and small or absent type 2A fibers. The disease is non-progressive or it progresses very slowly. Inheritance is autosomal dominant or recessive. {ECO:0000269|PubMed:11114175}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.231
Intolerance Scores
- LoFtool
- 0.0360
- RVIS EVS
- -2.09
- RVIS percentile EVS
- 1.57
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.611
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |